HEATHER SHULTZ: Open Payments
NPI 1548445588 · MORRISTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 39 payments from 14 companies in 2025. Trend: 2023 $710 · 2024 $954 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $193 |
| Lilly USA, LLC | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Novo Nordisk Inc | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| ABBVIE INC. | 2 | $30 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $21 |
Products named: IMDELLTRA (AMG757), MOUNJARO, CAPLYTA, OTEZLA, JARDIANCE, Wegovy, Kerendia, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
